THE USE OF RECOMBINANT FACTOR VIIA IN A PATIENT WITH ACQUIRED HEMOPHILIA-A UNDERGOING SURGERY

被引：11

作者：

DOUGHTY, HA

NORTHEAST, A

SKLAIR, L

ROQUES, T

YOUNG, AE

SAVIDGE, GF

HUNT, BJ

机构：

[1] ST THOMAS HOSP,CTR HAEMOPHILIA,LONDON SE1 7EH,ENGLAND

[2] ST THOMAS HOSP,DEPT SURG,LONDON SE1 7EH,ENGLAND

[3] WORTHING DIST HOSP,DEPT HAEMATOL,WORTHING,E SUSSEX,ENGLAND

来源：

BLOOD COAGULATION & FIBRINOLYSIS | 1995年 / 6卷 / 02期

关键词：

ACQUIRED HEMOPHILIA A; RECOMBINANT VIIA; SURGERY;

D O I：

10.1097/00001721-199504000-00006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

An elderly woman with acquired haemophilia A secondary to a monoclonal gammopathy, required elective surgery for a parotid tumour but was unable to tolerate conventional treatment, Recombinant activated factor VII (rVIIa) was used successfully to cover a biopsy and then subsequent resection of the tumour, The use of rVIIa in the management of acquired inhibitors is discussed.

引用

页码：125 / 128

页数：4

共 13 条

[1]

ABILDGAARD CF, 1981, NEW ENGL J MED, V304, P670

[2]

GLUECK HI, 1965, J CLIN INVEST, V441, P1866

[3] SPONTANEOUS INHIBITORS OF FACTOR 8 [J].